The impact of molecular and mismatch repair status on the survival outcomes of surgically treated patients with colorectal peritoneal metastases-Reference-Cited by-同舟云学术

The impact of molecular and mismatch repair status on the survival outcomes of surgically treated patients with colorectal peritoneal metastases

Published:2022-10 Issue:10 Volume:48 Page:2218-2225
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Flood Michael P.^ORCID,Jain Anshini^ORCID,Mitchell Catherine^ORCID,Hewitt Chelsee^ORCID,Ramsay Robert^ORCID,Michael Michael^ORCID,Heriot Alexander G.,Tie Jeanne^ORCID

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference38 articles.

1. Survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a systematic review and discussion of latest controversies;Flood;Surgeon,2021

2. Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: prognostic factors and oncologic outcome in a national patient cohort;Froysnes;J Surg Oncol,2016

3. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures;Passot;J Surg Oncol,2016

4. The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy;Wong;World J Surg Oncol,2020

5. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients;Baratti;Dis Colon Rectum,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis;European Journal of Surgical Oncology;2024-09

2. Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases;ESMO Open;2024-04

3. Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer;Cancers;2023-11-29

4. MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama;BMC Cancer;2023-06-06

5. Impact of Molecular Status on Cytoreductive Surgery for Peritoneal Metastases from Colorectal Cancer;Clinics in Colon and Rectal Surgery;2023-04-16